Securities Fraud Class Action Filed Against Hims & Hers Health

Key Facts

1A securities class action lawsuit has been filed against Hims & Hers Health, Inc. and certain company executives.

2The lawsuit stems from a Federal Trade Commission (FTC) complaint accusing the company of serious business misconduct.

3The lead plaintiff deadline for the class action has been set for November 2, 2026.

A securities class action lawsuit has been filed against Hims & Hers Health, Inc. and certain company executives. Newsfile Corp reported that the legal action stems from a federal complaint by the Federal Trade Commission (FTC) accusing the company of serious business misconduct, including sharing consumers' health information with third-party advertising platforms. The lead plaintiff deadline for the class action has been set for November 2, 2026.

The complaint further alleges that the company charges consumers for prescriptions almost immediately after intake forms are submitted, potentially subjecting it to heightened regulatory scrutiny and penalties. Regarding market performance, HIMS closed at $29.3 on October 1, 2026, having reached a day high of $29.88 and a low of $28.64 during that session.